1,2-distearoylphosphatidylethanolamine has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bredlau, AL; Broome, AM; Dixit, S; McKinnon, E; Miller, K; Moore, A | 1 |
| Géraudie, B; Kerrou, K; Malinge, J; Ménager, C; Nataf, V; Ou, P; Prignon, A; Provost, C; Savel, P; Siaugue, JM; Sollogoub, M; Talbot, JN; Zhang, Y | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Delayed-Action Preparations; Drug Delivery Systems; Glioblastoma; Humans; Mice, Nude; Micelles; Phosphatidylethanolamines; Protons; Receptors, Platelet-Derived Growth Factor; Temozolomide | 2016 |
Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies.
Topics: Acetates; Animals; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Glioblastoma; Glucose; Heterocyclic Compounds, 1-Ring; Humans; Lipids; Liposomes; Magnetic Fields; Magnetic Resonance Imaging; Mice; Mice, Nude; Phosphatidylethanolamines; Phospholipids; Polyethylene Glycols; Positron-Emission Tomography | 2017 |